-
Entity
-
Individual
-
Location
-
C/O Iteos Therapeutics, Inc., 139 Main Street, Cambridge, MA
-
Summary
-
The estimated net worth of Matthew Gall is at least $506K dollars as of November 19, 2024. Matthew Gall is the Chief Financial Officer of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $506K.